Citadel Advisors’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$604K Sell
119,117
-141,890
-54% -$719K ﹤0.01% 3847
2025
Q1
$788K Buy
261,007
+248,646
+2,012% +$751K ﹤0.01% 3537
2024
Q4
$44.7K Sell
12,361
-954,246
-99% -$3.45M ﹤0.01% 5484
2024
Q3
$1.7M Sell
966,607
-878,655
-48% -$1.55M ﹤0.01% 2650
2024
Q2
$2.88M Sell
1,845,262
-58,084
-3% -$90.6K ﹤0.01% 2109
2024
Q1
$3.71M Buy
1,903,346
+149,746
+9% +$292K ﹤0.01% 1986
2023
Q4
$2.47M Sell
1,753,600
-30,536
-2% -$43.1K ﹤0.01% 2227
2023
Q3
$2.82M Buy
1,784,136
+1,464,046
+457% +$2.31M ﹤0.01% 2083
2023
Q2
$691K Buy
320,090
+279,161
+682% +$603K ﹤0.01% 3338
2023
Q1
$86K Buy
40,929
+3,092
+8% +$6.49K ﹤0.01% 4973
2022
Q4
$82.9K Buy
+37,837
New +$82.9K ﹤0.01% 5098
2022
Q3
Hold
0
6837
2022
Q2
Sell
-159,921
Closed -$855K 7044
2022
Q1
$855K Sell
159,921
-33,573
-17% -$179K ﹤0.01% 3901
2021
Q4
$1.45M Sell
193,494
-6,921
-3% -$51.7K ﹤0.01% 3384
2021
Q3
$1.82M Buy
200,415
+170,542
+571% +$1.55M ﹤0.01% 3112
2021
Q2
$145K Buy
29,873
+16,403
+122% +$79.6K ﹤0.01% 5764
2021
Q1
$60K Buy
+13,470
New +$60K ﹤0.01% 6044
2020
Q3
Sell
-11,998
Closed -$53K 5364
2020
Q2
$53K Sell
11,998
-6,607
-36% -$29.2K ﹤0.01% 4363
2020
Q1
$52K Buy
18,605
+4,831
+35% +$13.5K ﹤0.01% 4541
2019
Q4
$57K Buy
+13,774
New +$57K ﹤0.01% 4371
2019
Q2
Sell
-5,782
Closed -$45K 5181
2019
Q1
$45K Buy
5,782
+3,534
+157% +$27.5K ﹤0.01% 4260
2018
Q4
$16K Buy
+2,248
New +$16K ﹤0.01% 4328
2018
Q3
Sell
-2,767
Closed -$35K 4797
2018
Q2
$35K Buy
+2,767
New +$35K ﹤0.01% 3961
2018
Q1
Sell
-917
Closed -$45K 4481
2017
Q4
$45K Buy
+917
New +$45K ﹤0.01% 3644
2016
Q1
Sell
-1,421
Closed -$195K 4050
2015
Q4
$195K Buy
+1,421
New +$195K ﹤0.01% 2974